Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026
Alpha Vantage · TradingView · · AI-summarised by FinFlash
Protagonist Therapeutics (PTGX) announced that senior management will participate in four investment bank conferences in November 2026, including the Wolfe Research Healthcare Conference, Truist Securities Biopharma Symposium, UBS Global Biopharma Conference, and Jefferies Global Healthcare Conference. The company will engage in fireside chats and one-on-one meetings with investors at these events.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.